Study Details
Stem Cell Transplants and Disease Prevention for Children with ALL, AML, or MDS
(IRB#: IRB_00153852)
Acute lymphocytic leukemia (ALL) is a type of blood and bone marrow cancer. Acute myeloid leukemia (AML) is a type of blood cell and bone marrow cancer caused by too many undeveloped white blood cells. Myelodysplastic Syndromes (MDS) are a rare group of bone marrow disorders, known as blood cancer. We want to learn if patients receiving stem cell transplants from donors of any type (related, unrelated, cord, or haploidentical) with specific characteristics (different genetic make-up known as polymorphisms) will have better results than those with different transplants. We want to see if fewer diseases such as Graft v Host Disease (GvHD) and other disorders occur. The information we gain may aid future patients.
- All genders
- All Ages
- Volunteers with special conditions
- In Person
- Unpaid
Who can participate?
Gender: All genders
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- < 25 years for receiving transplants
- 4 months and older for donors
- Diagnosis of ALL, AML, MDS
- High risk with first or second remission of ALL, AML, MDA
- In-person at the University of Utah
Exclusion Criteria
- Pregnant
- Diagnosis of HIV
- Active CNS (central nervous system) ALL
- Diagnosed genetic disorder(s)
Will I be paid for my time?
No
IRB#: IRB_00153852
PI: Michael Pulsipher
Department: PEDIATRIC HEMATOLOGY/ONCOLOGY
Approval Date: 2023-04-05 06:00:00
Specialties: Pediatric Hematology & Oncology